Filipa D. Amaro
Porto, 4050313, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Metabolic Reprogramming in Renal Cell Carcinoma: A Scoping Review with Quantitative Integration of Metabolomic Studies.
Journal: Journal of proteome research
Published: June 18, 2026
Correction to: Influence of pre‑analytical factors and biological variability on the urinary volatilome.
Journal: Analytical and bioanalytical chemistry
Published: May 21, 2026
Anticancer Potential of Cannabidiol in Renal Cell Carcinoma: Serum Modulation and Preliminary Mechanistic Insights.
Journal: Journal of clinical medicine
Published: December 12, 2025
On the Antimicrobial Potential of Asparagopsis armata's Ethanol Extract: A New Multiple-Industry Bio-Product?
Journal: International journal of molecular sciences
Published: October 13, 2025
Influence of pre-analytical factors and biological variability on the urinary volatilome.
Journal: Analytical and bioanalytical chemistry
Published: August 05, 2025
Paclitaxel resistance-associated metabolic events in ovarian cancer cells.
Journal: Metabolomics : Official journal of the Metabolomic Society
Published: July 07, 2025
Protective Role of the Natural Antioxidant Astaxanthin in Both Human Bronchial Epithelial Cells (BEAS-2B) and Non-Small Cell Lung Cancer Cells (H1975) Exposed to Cadmium: Impact on the Generation of Reactive Oxygen Species and Cancer Cell Migration.
Journal: Molecular nutrition & food research
Published: January 15, 2025
Metabolic signature of renal cell carcinoma tumours and its correlation with the urinary metabolome.
Metabolic signature of renal cell carcinoma tumours and its correlation with the urinary metabolome.
Journal: Metabolomics : Official journal of the Metabolomic Society
Published: October 19, 2024
Metabolomics Reveals Tyrosine Kinase Inhibitor Resistance-Associated Metabolic Events in Human Metastatic Renal Cancer Cells.
Journal: International journal of molecular sciences
Published: May 07, 2024
Impact of the redox-active MnTnHex-2-PyP5+ and cisplatin on the metabolome of non-small cell lung cancer cells.
Journal: Biochemical pharmacology
Published: March 04, 2024
Metabolic signature biomarkers for predicting the recurrence of urological cancers.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: July 24, 2023
MnTnHex-2-PyP5+ Displays Anticancer Properties and Enhances Cisplatin Effects in Non-Small Cell Lung Cancer Cells.
Journal: Antioxidants (Basel, Switzerland)
Published: September 15, 2022
Last Updated: 09/26/2026